Femring and dyspareunia Patient Reports February 10, 2012

Femring Side Effects Report #4643375-0
Femring side effect was reported by a Physician from on Apr 13, 2005. Female patient, 61 years of age, weighting 155.9 lb, was diagnosed with menopausal symptoms and was treated with Femring. After drug was administered, patient experienced the following side effects: antinuclear antibody positive, dyspareunia, excessive granulation tissue, medical device complication, vaginal disorder, vaginal examination abnormal. Femring dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with LIPITOR. Patient recovered.

Femring Side Effects Report #4920806-X
Femring side effect was reported by a Physician from UNITED STATES on May 13, 2004. Female patient, 61 years of age, weighting 155.9 lb, was diagnosed with menopausal symptoms and was treated with Femring. After drug was administered, patient experienced the following side effects: dyspareunia, hyperkeratosis, medical device complication, post procedural complication, rectocele, vaginal disorder, vaginal infection. Femring dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with LIPITOR, PREMARIN, CALCIUM, ACTONEL. Patient recovered.

Femring Side Effects Report #4668479-8
Femring side effect was reported by a Pharmacist from on May 10, 2005. Female patient, 56 years of age, weighting 115.1 lb, was diagnosed with menopausal symptoms, rosacea  and was treated with Femring. After drug was administered, patient experienced the following side effects: breast infection, breast mass, diarrhoea, dyspareunia, hot flush, vaginal mycosis, white blood cells stool positive. Femring dosage: unknown. During the same period patient was treated with METRONIDAZOLE. Patient recovered.

Femring Side Effects Report #4691423-4
Femring side effect was reported by a Consumer or non-health professional from on May 27, 2005. Female patient, 53 years of age, weighting 173.1 lb, was treated with Femring. After drug was administered, patient experienced the following side effects: breast mass, dyspareunia, vulvovaginal discomfort. Femring dosage: 0.05 MG, QD, VAGINAL. Patient recovered.


Femring Side Effects Report #4691423-4
Femring side effect was reported by a Consumer or non-health professional from UNITED STATES on May 27, 2005. Female patient, 53 years of age, weighting 173.1 lb, was treated with Femring. After drug was administered, patient experienced the following side effects: breast mass, complication of device insertion, dyspareunia, vulvovaginal discomfort. Femring dosage: 0.05 MG, QD, VAGINAL. Patient recovered.